Updated:
Xeris Pharmaceuticals
Xeris Pharmaceuticals, based in Tokyo and Chicago, invests in pharmaceutical and biotech opportunities across Japan and North America.
Xeris Pharmaceuticals
Xeris Pharmaceuticals maintains offices in Tokyo and Chicago, suggesting a dual-region operational footprint. The firm's name implies a focus on pharmaceutical and biotech investments, though specific founding details or principals are not publicly disclosed. The firm's strategy likely encompasses direct investments in pharmaceutical companies and related healthcare services across Japan and North America. Without public portfolio company names or deal records, the precise asset-class mix remains undisclosed. Team size and additional vehicles are not publicly available. No recent operational events have been recorded in the last 24 months. The structural differentiator for Xeris Pharmaceuticals appears to be its cross-border presence between Japan and the United States, which may provide access to distinct regulatory and market environments in both regions.
General information
Firm type
Asset Manager
Year founded
—
AUM
Undisclosed
Location
Region
Asia
Country
Japan
City
Tokyo
Corporate office
Tokyo, Japan
Additional offices
Chicago, United States
Sector focus
Frequently asked questions
What is the investment focus of Xeris Pharmaceuticals?
Xeris Pharmaceuticals appears to focus on pharmaceutical and biotech investments, with offices in Tokyo and Chicago indicating a cross-border strategy between Japan and the United States. Specific portfolio companies or sectors beyond healthcare are not publicly disclosed.
How is Xeris Pharmaceuticals structured?
Public records indicate the firm operates from Japan and the United States, but its legal structure — whether as a family office, asset manager, or holding company — is not specified in available sources.
Does Xeris Pharmaceuticals invest in early-stage or late-stage companies?
No public information details the investment stage preferences of Xeris Pharmaceuticals. The firm's focus on pharmaceuticals could imply involvement across development stages, but this is speculative without confirmed data.
What is the geographic focus of Xeris Pharmaceuticals?
The firm maintains offices in Tokyo (Japan) and Chicago (United States), suggesting investments primarily in these two regions. Broader geographic scope is not documented.
Who are the key principals at Xeris Pharmaceuticals?
No named principals or leadership team members for Xeris Pharmaceuticals are available in public sources. The firm's management structure remains undisclosed.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: